Another plausible option is that BCR‐ABL1 p190 protein, the most frequent isoform in ALL patients, contributes to the direct activation of CrkL, but also of Stat5 through Jak2 [41]. This evidence concerns the gene JAK2 and acute lymphoblastic leukemia.